Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.

Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.

The stem and progenitor cell compartments in low and intermediate-risk myelodysplastic syndromes (MDS) have recently been described, and shown to be highly conserved when compared to those in acute myeloid leukemia (AML). Much less is known about the characteristics of the hematopoietic hierarchy of...

Detaylı Bibliyografya
Asıl Yazarlar:	Dimitriou, M, Woll, P, Mortera-Blanco, T, Karimi, M, Wedge, D, Doolittle, H, Douagi, I, Papaemmanuil, E, Jacobsen, S, Hellström-Lindberg, E
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Impact Journals 2016

Benzer Materyaller

Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome
Yazar:: M A Pimenova, ve diğerleri
Baskı/Yayın Bilgisi: (2013-07-01)

A rare case of Fanconi’s anaemia with Myelodysplastic syndrome and complex cytogenetic abnormalities-Monosomy 7 and Down’s syndrome-A case report
Yazar:: Rama H, ve diğerleri
Baskı/Yayın Bilgisi: (2014-08-01)

Progression in patients with low- and intermediate1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations.
Yazar:: Scharenberg, C, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Myelodysplastic syndromes
Yazar:: Eva Hellström Lindberg
Baskı/Yayın Bilgisi: (2018-06-01)

A Child with Psoriasis, Hypogammaglobulinemia, and Monosomy 7-Positive Myelodysplastic Syndrome
Yazar:: Namik Özbek, ve diğerleri
Baskı/Yayın Bilgisi: (2015-02-01)

Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations
Yazar:: Christian Scharenberg, ve diğerleri
Baskı/Yayın Bilgisi: (2017-03-01)

S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
Yazar:: Charles Dussiau, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Myelodysplastic syndromes are multiclonal diseases derived from hematopoietic stem and progenitor cells
Yazar:: Bingqing Luo, ve diğerleri
Baskı/Yayın Bilgisi: (2022-05-01)

Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7
Yazar:: Victor B. Pastor, ve diğerleri
Baskı/Yayın Bilgisi: (2018-03-01)

Cytogenetic clonal evolution In myelodysplastic syndrome
Yazar:: Aw, Eunice Ching-Yi
Baskı/Yayın Bilgisi: (2018)

RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
Yazar:: Julie Schanz, ve diğerleri
Baskı/Yayın Bilgisi: (2015-04-01)

Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview
Yazar:: Mohammad Faizan Zahid, ve diğerleri
Baskı/Yayın Bilgisi: (2016-12-01)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Case series: Neurocognitive assessment of three siblings with SAMD9-associated monosomy 7/myelodysplastic syndrome
Yazar:: Diana L. Cohen, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

CLINICAL AND CYTOGENETIC PROFILE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME
Yazar:: Muneshwar Kumar, ve diğerleri
Baskı/Yayın Bilgisi: (2019-06-01)

Cytogenetic profile in patients with primary myelodysplastic syndrome
Yazar:: S V Gritsaev, ve diğerleri
Baskı/Yayın Bilgisi: (2013-07-01)

Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide
Yazar:: Gudrun Göhring, ve diğerleri
Baskı/Yayın Bilgisi: (2011-02-01)

The role and impact of Del(5q) and TP53 mutations on haematopoietic stem and progenitor cells during the progression of Myelodysplastic Syndrome to Acute Myeloid Leukaemia
Yazar:: Doolittle, H
Baskı/Yayın Bilgisi: (2017)

Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo.
Yazar:: Woll, P, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Myelodysplastic syndromes: moving towards personalized management
Yazar:: Eva Hellström-Lindberg, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

FLT3 expression initiates in fully multipotent mouse hematopoietic progenitor cells.
Yazar:: Buza-Vidas, N, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo
Yazar:: Woll, P, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Cytogenetic description of breast fibroadenomas: alterations related solely to proliferation?
Yazar:: R.R. Burbano, ve diğerleri
Baskı/Yayın Bilgisi: (2001-08-01)

Molecular Cytogenetics Of Myelodysplastic Syndrome – Hospital Based Study
Yazar:: Isa, Asmida
Baskı/Yayın Bilgisi: (2014)

Trisomy 14 as the only cytogenetic abnormality in myelodysplastic syndrome
Yazar:: M. N. Pautova, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Cytogenetic features in primary myelodysplastic syndrome Egyptian patients
Yazar:: Yasser Elnahass, ve diğerleri
Baskı/Yayın Bilgisi: (2018-03-01)

Cytogenetic study of Brazilian patients with myelodysplastic syndrome (MDS)
Yazar:: Tamara Borgonovo, ve diğerleri
Baskı/Yayın Bilgisi: (2005-12-01)

ETV6 deletion is a common additional abnormality in patients with myelodysplastic syndromes or acute myeloid leukemia and monosomy 7
Yazar:: Meaghan Wall, ve diğerleri
Baskı/Yayın Bilgisi: (2012-12-01)

High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia
Yazar:: Mohsen Karimi, ve diğerleri
Baskı/Yayın Bilgisi: (2015-06-01)

Erythroid differentiation enhances RNA mis-splicing in SF3B1-mutant myelodysplastic syndromes with ring sideroblasts
Yazar:: Moura, PL, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

IMPACT PROGNOSIS OF CYTOGENETIC ALTERATIONS IN BRAZILIAN CHILDHOOD MYELODYSPLASTIC NEOPLASM
Yazar:: Viviane Lovatel, ve diğerleri
Baskı/Yayın Bilgisi: (2023-12-01)

Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes
Yazar:: Minh Phuong Vu, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?
Yazar:: Sílvia Saumell, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Cystic Hygroma and Monosomy X
Yazar:: Aykut Özek, ve diğerleri
Baskı/Yayın Bilgisi: (2013-04-01)

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Identification of aberrant splicing events in myelodysplastic syndrome patients with splicing factor gene mutations
Yazar:: Pellagatti, A, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Erratum to Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo [Cancer Cell, 25 (2014) 794-808]
Yazar:: Woll, P, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Trisomy Chromosome 6 as a Sole Cytogenetic Abnormality in Acute Myeloid Leukemia
Yazar:: Monika Gupta, ve diğerleri
Baskı/Yayın Bilgisi: (2015-02-01)